☆ 4.6 Article

Daratumumab for refractory immune-mediated thrombotic thrombocytopenic purpura

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 202, Issue 2, Pages 429-433

Publisher

WILEY

DOI: 10.1111/bjh.18854

Keywords

daratumumab; plasma cell; refractory; thrombotic thrombocytopenic purpura (TTP)

Categories

Hematology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.